ERIC AGUIAR
CIK 1262325 · last filed 2026-06-24
ERIC AGUIAR is a corporate insider who has filed 48 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for BBIO, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$57.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.34M
6
48
$57.25M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 10,579 | $85.55 | $905.0K | $0 | 8 | 2026-06-24 |
| BMEA | Director | — | $1.25 | — | $0 | 6 | 2026-06-12 |
| Invitae Corp (NVTA) Delisted | Director | 3,857,782 | $0.09 | $343.7K | -$2.32M | 15 | 2023-05-01 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Director | 24,575,501 | — | — | $55.01M | 5 | 2020-05-29 |
| BHVN | Director | 31,400 | $13.77 | $432.4K | -$3.10M | 13 | 2020-01-24 |
| Altimmune, Inc. (HAQ.WS) Delisted | 10%+ Owner | 250,000 | — | — | $7.66M | 1 | 2007-08-07 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-24 | BBIO | Grant (A) | +3,990 | $0 | EDGAR |
| 2026-06-12 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2025-06-24 | BBIO | Grant (A) | +6,589 | $0 | EDGAR |
| 2025-06-13 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2023-05-01 | Invitae Corp (NVTA) Delisted | Grant (A) | +70,422 | $0 | EDGAR |
| 2022-06-24 | BMEA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.